The Chair of the Protocol Review and Monitoring Committee (PRMC) is responsible for the supervision and coordination of all aspects of the committee's mission to ensure that clinical cancer research in the HCCC is conducted within the framework of only the highest scientific and ethical standards. These responsibilities include: ? Supervision of work done relevant to the PRMC by the Protocol Administrator and Clerk III; ? Review of submitted protocols to ensure completeness and the most appropriate triage for review; ? Contact investigators who have submitted studies judged to be grossly deficient with advice on how to address the deficiency before a formal PRMC review; ? Facilitate a fair, appropriate and comprehensive discussion of each protocol in committee; ? Provide the Primary Investigator with a concise but thorough written critique of their study within 5 working days; ? Conduct annual reviews of all active HCCC clinical studies and assess each study for scientific relevancy and accrual, ? Collaborate with the Data and Safety Monitoring Committee Chair on studies that need to be closed for safety reasons and execute closure proceedings; ? Consult with the Associate Director for Clinical Research when difficult issues arise.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Iowa City
United States
Zip Code
Link, Brian K; Day, Bann-Mo; Zhou, Xiaolei et al. (2018) Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study. Br J Haematol :
Lorenzen, Allison W; Kiriazov, Boris; De Andrade, James P et al. (2018) Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community. Ann Surg Oncol 25:3004-3010
Knight, Julia A; Blackmore, Kristina M; Fan, Jing et al. (2018) The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. Breast Cancer Res 20:23
Peterson, Tabitha A; Stamnes, Mark A; Piper, Robert C (2018) A Yeast 2-Hybrid Screen in Batch to Compare Protein Interactions. J Vis Exp :
Erudaitius, Dieanira; Mantooth, Jacqueline; Huang, Andrew et al. (2018) Calculated cell-specific intracellular hydrogen peroxide concentration: Relevance in cancer cell susceptibility during ascorbate therapy. Free Radic Biol Med 120:356-367
Pophali, Priyanka A; Ip, Andrew; Larson, Melissa C et al. (2018) The association of physical activity before and after lymphoma diagnosis with survival outcomes. Am J Hematol 93:1543-1550
Garcia-Monclús, Silvia; López-Alemany, Roser; Almacellas-Rabaiget, Olga et al. (2018) EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. Int J Cancer 143:1188-1201
Towle, Tyrell R; Kulkarni, Chaitanya A; Oppegard, Lisa M et al. (2018) Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase. Bioorg Med Chem Lett 28:1903-1910
Meyerholz, David K; Sieren, Jessica C; Beck, Amanda P et al. (2018) Approaches to Evaluate Lung Inflammation in Translational Research. Vet Pathol 55:42-52
Khan, Rafiullah; Mott, Sarah L; Schultz, Allyson et al. (2018) Bloodless tandem autologous transplant in Jehovah's Witness patients. Bone Marrow Transplant 53:1428-1433

Showing the most recent 10 out of 1080 publications